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Human astrocytes are larger and more complex than
those of infraprimatemammals, suggesting that their
role in neural processing has expanded with evolu-
tion. To assess the cell-autonomous and species-
selective properties of human glia, we engrafted
human glial progenitor cells (GPCs) into neonatal
immunodeficient mice. Upon maturation, the recip-
ient brains exhibited large numbers and high propor-
tions of both human glial progenitors and astrocytes.
The engrafted human glia were gap-junction-
coupled to host astroglia, yet retained the size and
pleomorphism of hominid astroglia, and propagated
Ca2+ signals 3-fold faster than their hosts. Long-term
potentiation (LTP) was sharply enhanced in the
human glial chimeric mice, as was their learning, as
assessed by Barnes maze navigation, object-loca-
tion memory, and both contextual and tone fear
conditioning. Mice allografted with murine GPCs
showed no enhancement of either LTP or learning.
These findings indicate that human glia differentially
enhance both activity-dependent plasticity and
learning in mice.
INTRODUCTION
The unique processing capabilities of the human brain reflect
a number of evolutionary adaptations by its cellular constituents
(Fields, 2004). One especially distinct feature of the adult human
brain’s cellular composition is the size and complexity of its
astrocytic cohort. Human astrocytes are both morphologically
and functionally distinct from those of infraprimate mammals,
in that human astroglia are larger and exhibit far greater architec-
tural complexity and cellular pleomorphism, as well as more
rapid syncytial calcium signaling, than their murine counterparts342 Cell Stem Cell 12, 342–353, March 7, 2013 ª2013 Elsevier Inc.(Colombo, 1996; Oberheim et al., 2009). These phylogenetic
differences are of particular interest, since astrocytes can both
coordinate and modulate neural signal transmission (Rusakov
et al., 2011; Verkhratsky et al., 1998). These observations
promise to fundamentally transform our view of astrocytes, since
current concepts of the role of astrocytes in neural network
performance are based almost entirely on studies of astrocytic
physiology in the rodent brain (Oberheim et al., 2006).
In this study, we have used a human glial chimericmouse brain
to ask whether the structural complexity and unique functional
properties of human astrocytes influence activity-dependent
plasticity in an otherwise stable neural network. In particular,
we have tested the hypothesis that human astrocytes might
enhance synaptic plasticity and learning relative to their murine
counterparts.
RESULTS
Human Glial Progenitors Exhibit Cell-Autonomous
Astrocytic Differentiation in Mouse Brain
To study human astrocytes in the live adult brain, we generated
chimeric mice in which human glial progenitor cells (GPCs)—iso-
lated by being sorted on the basis of an A2B5+/PSA-NCAM
phenotype, and then being expanded via a protocol that
promoted differentiation into hGFAP- and A2B5-expressing
astrocytes (Figure S1A available online)—were xenografted
into neonatal immune-deficient mice; these matured to become
adults chimeric for both mouse and human astroglia (Windrem
et al., 2004, 2008) (Figure 1A). The human GPCs were labeled
ex vivo, prior to implantation, with VSVg-pseudotyped
lentiviral-CMV-EGFP; in antecedent pilot experiments, we had
determined that this vector sustained the expression of EGFP
by astroglia for at least 1 year in vivo (Figure 1A). The neonatally
implantedmice were sacrificed at time points ranging from 0.5 to
20 months of age, and their brains were assessed both histolog-
ically and electrophysiologically. Human donor cells were first
identified based on their expression of human nuclear antigen
(hNuclei). The hNuclei+ cells were found to distribute relatively
evenly throughout the forebrain, infiltrating both hippocampus
Figure 1. Human Astrocytes Replace Host Glia in Mice Engrafted with Human Glial Progenitors
(A) Schematic outlining the procedure for magnetic cell sort-based isolation (MACS) of human glial progenitors, tagging with EGFP, and xenografting at P1. The
chimeric mice brains were analyzed in 0.5- to 20-month-old chimeric mice.
(B) Representative dot map showing the distribution of human nuclear antigen (hNuclei)+ cells in three coronal sections from a 10-month-old human chimeric
mouse.
(C) The complex fine structure of human astrocytes in chimeric brain replicates the classical star-shaped appearance of human astrocytes labeled with hGFAP
in situ. Most cells in the field are EGFP+/hNuclei+/hGFAP+ (hGFAP, red). Arrows in (C) through (F) show representative examples of human cells (hNuclei, white).
(D) At 5 months, EGFP+ cells typically infiltrated corpus callosum and cortical layers V and VI. All EGFP+ cells labeled with an antibody directed against human
nuclear antigen (hNuclei) and most of the human cells were also labeled with an antibody directed against human GFAP (hGFAP, red).
(E) At 11 months, many areas of cortex were infiltrated by evenly distributed EGFP+/hNuclei+ cells.
(F) The hippocampus was also populated with EGFP+/hNuclei+ cells in a 14-month-old animal, with the highest density in the dentate.
(G) Human EGFP+/hNuclei+/GFAP+ cells (green arrows) were significantly larger than host murine astrocytes (red arrow). The anti-GFAP antibody cross-reacted
with both human and mouse GFAP (red). Inset shows same field in lower magnification.
(H) Histogram comparing the diameter of mouse cortical astrocytes to human cortical astrocytes in situ (freshly resected surgical samples) and xenografted
human astrocytes in cortex of chimeric mouse brain. The maximal diameter of mouse and human astrocytes (in situ and in chimeric mice) was determined in
sections stained with an anti-GFAP antibody that labels both human and mouse GFAP. (n = 50–65; **p < 0.01, Bonferroni t test.)
EGFP, green; hNuclei, white and white arrow; DAPI, blue (B–F). Scale bars: 50 mm (C); 100 mm (D–F); and 10 mm (G). Data graphed as means ± SEM. See also
Figure S1.
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Human Glia Enhance Learning in Miceand cortex (Figure 1B). Human astrocytes were specifically iden-
tified by their intricate EGFP+ fluorescent processes and, in fixed
tissue, by their coexpression of human glial fibrillary acidic
protein (hGFAP) and hNuclei (Figure 1C). By 4–5 months of
age, mice engrafted with human GPCs exhibited substantial
addition of human astrocytes to both the hippocampus and
deep neocortical layers; by 12–20 months, human astrocytes
further populated large regions of the amygdala, thalamus, neo-
striatum, and cortex (Figures 1D–1F). The human astrocytes
appeared to develop and mature in a cell-autonomous fashion,
maintaining their larger size and more complex structure relative
to murine astrocytes (Figures 1G and 1H).
Human astrocytes, defined as EGFP+/hGFAP+/hNuclei+,
regularly extended processes that terminated in end-feet contig-
uously arrayed along blood vessel walls (Figures 2A and 2B).
Their long processes were often tortuous and resembled the
processes of interlaminar astroglia, a phenotype previouslyCdescribed only in adult human and ape brain (Oberheim et al.,
2006) (Figure 2C); these cells are characterized by long,
unbranched processes that traverse multiple cortical laminae
(Colombo, 2001). Many of the engrafted human astrocytes in
chimeric mice extended processes that spanned >0.5 mm
(Figure 2D). A large number of mitochondria were present in
the long processes (Figure 2E). Other engrafted human cells ex-
hibited the long, varicosity-studded processes of varicose
projection astrocytes, a second class of hominid astrocytes
(Oberheim et al., 2009).
Of note, rag2/ immunodeficient mice on a C3h background
were generally used as recipients for these experiments,
although rag1/ immunodeficient mice (on a C57/Bl6 back-
ground) were used for vision-dependent behavioral tests, since
the C3h background of the rag2mice is a visually impaired strain;
we observed no difference in xenograft acceptance, cell
dispersal, or differentiation patterns between these two hosts.ell Stem Cell 12, 342–353, March 7, 2013 ª2013 Elsevier Inc. 343
Figure 2. Human Astrocytes Retain Hominid-Specific Morphologies in Chimeric Mice
Human protoplasmic astrocytes matured in a cell-autonomous fashion in the chimeric mouse brain environment and retained the long GFAP+, mitochondrial-
enriched processes of native human astroglia.
(A) An EGFP+/hGFAP+ astrocyte makes contact with the vasculature in a 1-month-old chimeric mouse.
(B) Long, unbranched EGFP+ and hGFAP+ astrocytic processes terminated (dashed circle) on the vasculature (laminin; white) 16 days after implantation.
(C) The tortuous shape of EGFP+/hGFAP+ processes in chimeric brains replicate the appearance of GFAP+ processes of interlaminar astroglia in intact human
tissue.
(D) An example of an EGFP+/GFAP+ process that spans >600 mm and penetrates the domains of at least 14 host murine astrocytes (white arrow) (GFAP, red).
(E) Long EGFP+ processes contain a large number of mitochondria (white) in an 11-month-old chimeric mouse.
(F) An EGFP+/hGFAP+ human astrocyte expresses Cx43 (white) gap junction plaques (left panel). An EGFP+ cell (green arrow) loaded with a small gap junction
permeable tracer, Alexa 594 (MW 760) in a cortical slice (P15), is also shown. Alexa 594 (red) diffused into multiple neighboring EGFP cells (red arrows).
(G) Coexistence of hGFAP+ (red)/hNuclei+ (white) cells (red arrows) and hNG2+ (green)/hNuclei+ cells (green arrows) in the dentate of a 12-month-old chimeric
mouse.
EGFP, green (A–F); hGFAP, red (A–C). Scale bars: 10 mm (A and C); 20 mm (B, E, and G); 50 mm (D and F, right panel); and 5 mm (F, left panel). See also Figure S2.
Cell Stem Cell
Human Glia Enhance Learning in MiceIn that regard, we found no evidence of microglial activation in
the xenografted mice, whether in rag1 null or rag2 null hosts,
reflecting both their neonatal engraftment and immunodeficient
backgrounds (Figures S1B–S1F).
Human Astrocytes Coupled Structurally and
Functionally with Mouse Astrocytes
Their cell-autonomous maturation and morphologies notwith-
standing, the engrafted human cells rapidly integrated with
murine host cells. The gap junction tracer Alexa 594 (MW
760), once injected into EGFP+ human cells, spread rapidly344 Cell Stem Cell 12, 342–353, March 7, 2013 ª2013 Elsevier Inc.into multiple neighboring EGFP host cells, suggesting the
competence of interspecies gap junctions linking human and
mouse astroglia, likely derived from the apposition of human
and mouse Cx43 hemichannels (Figure 2F). A large number of
hNuclei+ cells failed to express GFAP but did express
a human-specific isoform of the chondroitin sulfate proteo-
glycan NG2 (Figure 2G), a prototypic marker of parenchymal
glial progenitor cells (Mangin and Gallo, 2011; Robel et al.,
2011). Of note, hGFAP+ and hNG2+ human cells often coexisted
in close proximity, although their relative ratios exhibited consid-
erable variation across regions as well as between individual
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Human Glia Enhance Learning in Micemice (Figure 2G). Transferrin immunostaining failed to detect
any human oligodendroglia, consistent with our prior assess-
ment of glial progenitor cell fate upon transplantation to normally
myelinated brain (Windrem et al., 2009) (Figures S2A and S2B):
whereas a large proportion of engrafted human GPCs differen-
tiate into oligodendrocytes in hypomyelinated shiverer mice,
essentially no human oligodendrocytes were found in similarly
engrafted wild-type mice (Windrem et al., 2009).
Human GPCs and Astrocytes Exhibited Distinct
Physiological Phenotypes in Mouse Brain
To evaluate the electrophysiological properties of human astro-
cytes engrafted in mice, acute hippocampal slices were
prepared from chimeric mice ranging from 4 to 10 months of
age (6.5 ± 0.4 months old, mean ± SD). Donor astrocytes could
be readily identified by their EGFP fluorescence and by their
large, symmetric, highly branched astrocytic morphologies.
The tagged donor cells were filled with Alexa 594 or the Ca2+
indicator rhod2 during whole-cell recordings, and their pheno-
type was verified by immunolabeling for GFAP (Figure 3A).
EGFP+ human astrocytes exhibited a higher input resistance
than that of host murine astrocytes (51.6 ± 2.5MU, n = 37, versus
29.2 ± 3.2 MU, n = 17, respectively, means ± SEM; p < 0.05,
Steel-Dwass test). In contrast, the resting membrane potential
of human astrocytes (69.2 ± 1.5 mV, n = 37) was not signifi-
cantly different from that of untagged host astrocytes
(73.9 ± 1.7 mV, n = 17, p > 0.05) (Figures 3B–3D). Whereas
all large and symmetric EGFP+ donor cells exhibited passive
membrane currents and linear current to voltage (I/V) curves,
another population of smaller EGFP+ human cells with compact,
asymmetrically branched morphologies manifested a much
higher input resistance (147.8 ± 11.7 MU, n = 14). These donor
cells manifested voltage-gated currents and depolarization-trig-
gered outward currents with delayed activation (Figure 3B) and
expressed a human epitope of chondroitin sulfate proteoglycan
NG2, identifying them as persistent glial progenitors (Figure 2G)
(Kang et al., 2010; Robel et al., 2011). Together, these histolog-
ical and electrophysiological analyses supported the notion that
a large proportion of engrafted human cells differentiated into
protoplasmic astrocytes, forming a functional syncytium with
their murine host, and that these were accompanied by large
numbers of coengrafted NG2+ human glial progenitors.
Human Astrocytes Propagate Calcium Waves More
Quickly than Do Murine Astroglia
Astrocytes are electrically nonexcitable and are incapable of
electrochemical communication. Instead, the principle mecha-
nism of astrocytic signaling involves transient elevations of cyto-
solic Ca2+ (Cotrina and Nedergaard, 2005). In light of the larger
and more complex architecture of human astrocytes, we next
askedwhether propagation of intracellular Ca2+ signals in human
astrocytes differs from that of rodents. To compare intracellular
Ca2+ wave propagation between human and mouse astrocytes,
we initiated localized Ca2+ increases by photolysis of cagedCa2+
(Parpura and Verkhratsky, 2012; Rusakov et al., 2011). Photol-
ysis of caged Ca2 loaded specifically into astrocytes was used
to avoid potentially confounding alterations in local synaptic
activity. Intracellular Ca2+ waves were evoked when we directed
a UV beam at long processes of astrocytes filled with rhod2 andCNP-EGTA by a patch pipette. The subsequent spread of Ca2+
signals was visualized using two-photon excitation (Figure 3E).
Line scanning with high temporal resolution (2–4 ms) showed
that intracellular Ca2+ wave propagation was significantly faster
in human astrocytes than in murine cells; intracellular Ca2+
increases propagated with a velocity of 15.8 ± 0.7 mm/s among
human glia compared to 5.7 ± 0.4 mm/s in resident murine astro-
cytes (n = 22–34, 6.5 ± 0.4 versus 7.0 ± 0.5 months old, mean ±
SEM, p < 0.05, Steel-Dwass test) (Figures 3F–3H). To determine
whether the faster intracellular Ca2+ waves in human astrocytes
were an artifact of xenograft, we also assessed intracellular Ca2+
wave spread in slices of fresh human brain tissue obtained at
surgical resection for distant lesions (mean age of patients:
30.6 ± 8.8 years, n = 3). Human astrocytes in these surgical
resections similarly propagated intracellular Ca2+ waves much
more rapidly than did murine astrocytes (n = 10) (Figure 3H).
Together, these experiments demonstrated that intracellular
Ca2+ signals propagate at least 3-fold faster within human astro-
cytes than in their rodent counterparts, and do so in human glial
chimeric mice just as in human brain tissue. Of note, we were
unable to evaluate intercellular Ca2+ wave propagation, as only
slices prepared from young mice pups load well with esterified
(AM) Ca2+ indicators (Dawitz et al., 2011).
Human Astrocytes Accentuate Excitatory Synaptic
Transmission in the Murine Hippocampus
A principal function of astrocytes is to monitor local synaptic
activity by their expression of metabotropic neurotransmitter
receptors for both glutamate and GABA (Parpura and
Verkhratsky, 2012; Rusakov et al., 2011). These receptors acti-
vate intracellular signaling pathways, mediated primarily by
increases in cytosolic Ca2+, which are linked to synaptic plas-
ticity (Parpura and Zorec, 2010). To assess the selective impact
of human astrocytes on neural transmission within the host
murine neural network, we compared synaptic activity in hippo-
campal slices prepared from human glial chimeric mice to that of
both their unengrafted and allografted littermate controls. We
focused on the hippocampal dentate granule layer because of
the many electrophysiological and behavioral tests by which
hippocampal function, learning, and LTP could be assessed
(Lee and Silva, 2009). In addition, human cells typically densely
engrafted this area; these included an admixture of GFAP+/
hNuclei+ andNG2+/hNuclei+ cells (Figures 1B, 1F, and 2G). Stim-
ulation of the medial perforant path (Colino and Malenka, 1993)
consistently evoked a significantly steeper slope of field excit-
atory postsynaptic potentials (fEPSP) in the humanized chimeric
mice than that in either their uninjected littermates ormouseGPC
allografted controls (n = 3–40, F = 3.15, by two-way ANOVA,
p = 0.044) (Figure 4A). The allograft controls comprised a set of
mice neonatally engrafted with murine GPCs derived from
EGFP transgenic mice, and they otherwise underwent the
same isolation and engraftment protocols as those using human
GPCs. The steeper slope of the fEPSPs in the humanized
chimeras compared to that of the uninjected controls was still
evident after normalization to the fiber volley amplitudes,
a measure thought to reflect the number of stimulated axons
(Figure S3A). Thus, slices with human glia exhibited a significant
enhancement in their basal level of excitatory synaptic transmis-
sion over a wide range of stimulation intensities.ell Stem Cell 12, 342–353, March 7, 2013 ª2013 Elsevier Inc. 345
Figure 3. Functional Properties Indicate
High-Density Host Engraftment by Both
Human Glial Progenitors and Astrocytes
(A) Large and symmetric EGFP+ cell (green) in
an acute cortical slice prepared from a mouse
engrafted with human EGFP+ glial progenitors
4 months earlier. Inset: lower magnification of
the same field. The EGFP+ cell was loaded
with rhod2 (red) by a patch pipette. Rhod2
diffused into several neighboring EGFP cells
(white arrows, top panel). Cell identity was
verified when we immunolabeled against GFAP
(red, below panel). Neighboring cells were
GFAP+ and their shape was characteristic of
mouse astrocytes, indicating that the human
EGFP+/GFAP+ astrocytes were coupled by
functional gap junctions to host GFAP+ astro-
cytes.
(B) I/V curves from host mouse astrocytes (n = 17);
smaller, less complex EGFP+ human cells,
presumably glial progenitor cells (n = 14); and
large and symmetric human EGFP+ cells,
presumably astrocytes (n = 37).
(C and D) Comparison of the input resistance
and gap-junction-coupled cells detected as
the number of neighboring cells labeled with
Alexa 594. Mouse and large EGFP+ cells
(presumed human astrocytes) both manifested
low input resistance and were extensively
coupled by gap junctions. In contrast, small
EGFP+ cells—presumed human GPCs—ex-
hibited high input resistance and were not gap
junction coupled. (n = 14–37, *p < 0.05, Steel-
Dwass test.) Membrane potentials were not
significantly different.
(E) Photolysis of caged Ca2+ in an EGFP+ as-
trocytic process. White ‘‘X’’ shows initiated point;
white arrowhead shows Ca2+ propagation.
(F) Top: line scan position across the length of
a mouse astrocyte filled with NP-EGTA and rhod2.
Bottom: line scan image of an intra-astrocytic
Ca2+ wave initiated by photolysis of the cell body.
White dashed line indicates the velocity of the
intracellular Ca2+ wave.
(G) Line scan image of a human astrocyte in
a chimeric mouse.
(H) Comparison of velocities of intracellular Ca2+
waves in host murine and engrafted human
EGFP+ astrocytes and in human astrocytes in
freshly resected surgical tissue. (n = 8–35,
*p < 0.05, Steel-Dwass test.)
Scale bars: 30 mm (A); 100 mm (A, insert);
20 mm (B); and 10 mm (E). Data graphed as
means ± SEM.
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Hippocampus
We next asked if human astrocytes might affect synaptic
plasticity by assessing the effect of human glia on long-term
potentiation (LTP). Two trains of high-frequency stimulation346 Cell Stem Cell 12, 342–353, March 7, 2013 ª2013 Elsevier Inc.(HFS) potentiated the fEPSP slope to
151.2% ± 8.1% of baseline in chimeric
mice, compared with 138.6% ± 7.6%
in control littermates (n = 7 mice inboth groups, 13.8 ± 1.1 versus 12.6 ± 0.4 months old, re-
spectively, ages provided as mean ± SEM) (Figure 4B). The
enhancement of fEPSP slope persisted at 60 min in humanized
chimeric mice (113.6% ± 3.8%, p < 0.05), whereas fEPSP slope
in unengrafted controls fell to 103.2% ± 3.9% (not significantly
Figure 4. Strengthening of Excitatory
Transmission and Synaptic Plasticity in
Murine Brain by Engrafting of Human Glial
Cells
(A) Comparison of field EPSPs (fEPSPs) in human-
ized chimeric mice and their unengrafted littermate
andmouseGPC allografted controls. The slopes of
fEPSP were significantly increased in human
chimeric mice. (n = 3–40, F = 3.15, by two-way
ANOVA with Bonferroni post hoc t test, *p < 0.05).
(B) Induction of LTP by two trains of high-
frequency stimulation (each train consisted of
100 pulses at 100 Hz, with 30 s between bursts) in
human chimeric mice, but not in unengrafted
littermates and allografted mice. (n = 7 mice each
group, *p < 0.05, t test compared between before
and 60 min after the stimulation for each group.)
(C) Relative decreased percentage of fEPSP by
addition of NMDA receptor antagonist APV
(50 mM) in each group (n = 15–27).
(D) The adenosine A1 receptor antagonist DPCPX
failed to increase the fEPSP slope in unengrafted
rag2 controls (100 nM DPCPX, n = 8, p > 0.05,
Bonferroni test).
(E) The adenosine A1 receptor antagonist DPCPX
did not decrease the threshold for induction of LTP
in unengrafted controls; the fEPSP slope returned
to101.9%±3.6%by60minafterHFS,similar to the
rate of extinction in untreated slices (n = 8, t test).
Data graphed as means ± SEM. See also Fig-
ure S3.
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Mouse allografted controls exhibited an initial increase to
138.5% ± 2.3%, which fell to 103.8% ± 1.3% at 60 min (not
significantly different from the fEPSP slope prior to HFS, n = 7,
14.0 ± 0.1 months old, p = 0.29, t test) (Figure 4B). Thus, the
observed enhancement of LTP was a specific feature of human
glial chimerization, and was not attributable to cell engraftment
per se.
The enhancement of LTP can result from both presynaptic
and postsynaptic mechanisms. An analysis of paired-pulse
facilitation before and after HFS in chimeric mice suggested
that postsynaptic mechanisms most likely underlie the
enhancement of fEPSP slope in humanized chimeric mice
(Figures S3B and S3C). To evaluate the relative contribution
of AMPA- and NMDA-receptor-mediated currents to the
enhancement in LTP in the chimeric mice, we analyzed the
effect of NMDA receptor blockade using the NMDA receptor
antagonist APV. We found that the NMDA receptor component
accounted for only 4.7%–12% of fEPSP, with no significant
differences across the groups analyzed, indicating that NMDA
NR1 expression was not increased in the human glial chimeras.
These findings suggest that NMDA receptor activation played
a minor role, if any, in the enhancement of synaptic plasticity
in the chimeric mice (n = 15–27) (Figure 4C). Since NMDA
receptors have a higher affinity for glutamate than do AMPA
receptors (Malinow and Malenka, 2002), these observations
also suggest that the potentiation of fEPSPs in human glial
chimeric mice was not the result of increased synaptic release
of glutamate; this is consistent with the lack of enhancement
of paired-pulse suppression in the chimeric mice (Figures S3B
and S3C).CNeither Adenosine nor D-Serine Accounted for the
Enhancement of LTP by Human Glia
Several mechanisms exist by which astrocytes can modulate
excitatory transmission. Astrocytes release ATP, which, after
degradation to adenosine by extracellular ectonucleotidases,
can suppress both basal synaptic transmission and activity-
dependent increases in synaptic strength (Pascual et al., 2005;
Zhang et al., 2003). However, it seems unlikely that adenosine
contributed to the enhanced synaptic strength observed in the
xenografted mice. The A1 receptor antagonist 8-cyclopentyl-
1,3-dipropylxanthine (DPCPX) (Grover and Teyler, 1993; Wu
and Saggau, 1994) did not decrease the threshold for induction
of LTP in control mice; in slices exposed to 100 nM DPCPX, the
fEPSP slope returned to 101.9%± 3.6%60min after HFS, similar
to untreated slices (Figures 4D and 4E). Thus, it is unlikely that the
reduced threshold for LTP in chimeric mice was a consequence
of altered adenosine concentrations.
Astrocytes can also modulate excitatory transmission via their
release of D-serine (Panatier et al., 2006; Yang et al., 2003).
D-serine acts as an endogenous coagonist of NMDA receptors
and facilitates NMDA receptor activation, thereby potentiating
the insertion of additional AMPA receptors into the postsynaptic
membrane (Panatier et al., 2006; Yang et al., 2003). We tested
the effect of adding D-serine to the bath of slices prepared
from control mice. D-serine had no effects on the fEPSP slopes
in accordance with previous reports (p = 0.216, n = 6) (Panatier
et al., 2006; Yang et al., 2003). Moreover, neither D-serine nor
immunolabeling for its synthetic enzyme, serine racemase,
differed between human glial chimeric and uninjected control
mice (Figures S3D and S3E). These observations suggest that
the lower threshold for induction of LTP in human glial chimericsell Stem Cell 12, 342–353, March 7, 2013 ª2013 Elsevier Inc. 347
Figure 5. Astrocytic TNFa Contributes to LTP Facilitation in Chimeric Mice, which Is Attenuated by Thalidomide
(A) Hippocampal slices prepared from littermate control immunodeficient mice exhibited a potentiation of fEPSP in response to TNFa (n = 6, 12–16 months,
*p < 0.05, **p < 0.01, Bonferroni post hoc t test). Inset: fEPSP slopes plotted as a function of fiber volley amplitude.
(B) Hippocampal slices exposed to TNFa (600 nM; 2–4 hr) exhibited an increase in the intensity of the GluR1 subunit of AMPA receptors as seen via
immunolabeling, but not in that of the NR1 subunit of NMDA receptors (n = 5, 9–11 months, **p < 0.01, t test).
(C) Human chimeric mice exhibited a higher intensity of immunolabeling for TNFa and GluR1, but not for NR1 (n = 7, 7–20 months, *p < 0.05, **p < 0.01, t test).
(hNuclei, white; representative human cells, white arrows).
(D) Thalidomide also decreased the immunolabeling of TNFa and GluR1, but not that of NR1, in chimeric mice (hNuclei, white; n = 6, 12–16 months, *p < 0.05,
**p < 0.01, t test).
(E) The facilitation of LTP in chimeric micewas impaired by thalidomide (n = 6, 12.6 ± 0.3 versus 12.5 ± 0.5months old, respectively, means ± SEM, p < 0.05, t test).
(F) Thalidomide did not change the contribution of NMDA receptor activation to fEPSP. Recordings of fEPSPs were obtained before and after addition of the
NMDA receptor antagonist APV (50 mM), and the difference was calculated (n = 4).
(G) Phosphorylation of the Ser831 site of GluR1 was increased in chimeric mice compared with unengrafted littermate controls. Thalidomide attenuated the
increase in phosphorylation of the Ser831 site of GluR1, but had no effect in unengrafted littermate controls, white arrows shows hNuclei+ cells. (n = 6,
9–16 months, *p < 0.05, t test).
Scale bars: 100 mm (B, C, D, and G). All data are graphed as means ± SEM. See also Figure S4.
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glial release of D-serine.
Human Glial TNFa Potentiates Synaptic Transmission
via an Increase in GluR1 Receptors
Release of the cytokine TNFa comprises an alternative mecha-
nism by which glia might modulate LTP. Cultured astrocytes
constitutively release TNFa, which induces the addition of
AMPA receptors to neuronal membranes, thereby enhancing348 Cell Stem Cell 12, 342–353, March 7, 2013 ª2013 Elsevier Inc.excitatory synaptic transmission (Beattie et al., 2002; Stellwagen
and Malenka, 2006). To assess the involvement of TNFa in the
strengthening of excitatory transmission in the human glial
chimeric mice, we first confirmed that TNFa increased both
AMPA receptor current (Figure 5A) and AMPA GluR1 immuno-
labeling in hippocampal slices (Figure 5B). In contrast, TNFa
did not affect expression of the NMDA receptor NR1 subunit in
the same slices (Figure 5B). On that basis, we next asked
whether chimeric mice expressed human TNFa. Using qPCR
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Human Glia Enhance Learning in Micewe found that human-specific sequence encoding TNFa was
indeed highly expressed in the chimeras, yet undetectable in
unengrafted mice (Figure S4A). Immunolabeling confirmed that
the human glial chimeras exhibited significant increases in
both TNFa and GluR1, but not in NR1 (Figure 5C). We thus asked
whether the inhibition of TNFa production might suppress excit-
atory hippocampal transmission in chimeric mice, and if so,
whether TNFa inhibition might abrogate the effects of human
glial chimerization on LTP.
Previous studies have analyzed the effect of TNFa on excit-
atory transmission in vitro by adding soluble TNFR1 receptors
to scavenge free TNFa (Beattie et al., 2002; Stellwagen and
Malenka, 2006). Since soluble TNFR1 would not be expected
to be an efficient inhibitor in vivo, we instead administered thalid-
omide, a potent, BBB permeable inhibitor of TNFa production
(Ryu and McLarnon, 2008). Human glial chimeric mice treated
with thalidomide exhibited a significant suppression of fEPSP
slopes compared to those receiving vehicle (0.5% carboxy-
methylcellulose) (1.41 ± 0.15 mV/ms versus 1.05 ± 0.24 mV/ms
at 0.1 mA, means ± SEM, p < 0.05, n = 12). In contrast, excitatory
transmission in unengrafted littermates was unaffected by
thalidomide (1.02 ± 0.12 mV/ms versus 0.97 ± 0.20 mV/ms at
0.1 mA, p = 0.32, n = 12). These observations suggested that
thalidomide selectively targeted the potentiation of excitatory
transmissionmediated by human glial TNFa. Accordingly, thalid-
omide also reduced the expression of both TNFa and GluR1 in
the human glial chimeras, but not that of NR1 (Figure 5D). Impor-
tantly, thalidomide also prevented the facilitation of LTP in the
human glial chimeras: two trains of HFS failed to trigger LTP in
slices taken from chimeras pretreated with thalidomide
(106.3% ± 3.9%, n = 6, 12.6 ± 0.3 months of age), whereas the
activity-dependent potentiation of fEPSPs persisted in vehicle-
treated human glial chimeras (117.6% ± 4.8%, n = 6, 12.5 ±
0.5 months, p < 0.05, t test) (Figure 5E). Thalidomide did not alter
the number of NMDA receptors activated in response to medial
perforant-path fiber stimulation in either chimeric or unengrafted
controls, suggesting that thalidomide specifically suppressed
the number of functional AMPA receptors consistent with prior
publications showing that TNFa drives membrane insertion of
AMPA receptors (Figure 5F) (Beattie et al., 2002; Stellwagen
and Malenka, 2006). Thus, TNFa released by human glial cells
(Figure S4A, Figure 5C) enhanced host neuronal fEPSPs by
increasing the number of functional postsynaptic GluR1 AMPA
receptors (Figure 5C), and conversely, thalidomide suppressed
plasma membrane insertion of AMPA receptors, but not NMDA
receptors, by inhibiting TNFa production (Figure 5D).
TNFa regulates a number of cellular processes through protein
kinase C (PKC)-mediated phosphorylation (Faurschou and
Gniadecki, 2008), which is thus disrupted by thalidomide. Since
phosphorylation of GluR1, at sites critical for its synaptic
delivery, is both necessary and sufficient for lowering the
threshold for inducing LTP (Hu et al., 2007), we thus next asked
if the phosphorylation state of the GluR1 subunit differed
between human glial chimeric mice and their littermate controls.
We focused on two phosphorylation sites, Ser845 (PKA site) and
Ser831 (PKC/CaMKII site), each of which is critical for the
synaptic insertion of GluR1 (Hu et al., 2007), and assessed the
effects upon each of human glial chimerization and of thalido-
mide. Quantitative immunohistochemistry revealed that humanCglial chimeric mice exhibited a significant increase in Ser831
phosphorylation, the PKC-sensitive site (n = 6, p = 0.008,
t test); this was significantly attenuated in human glial chimeras
receiving thalidomide, but not in their unengrafted control litter-
mates (n = 9–10; p > 0.4, t test) (Figure 5G). In contrast, phos-
phorylation of the Ser845 PKA site was unaffected either by
the engraftment of human glia or by thalidomide (n = 6, p >
0.05, t test) (Figures S4B and S4C). Together, these results sug-
gested that human glia facilitate synaptic insertion of the GluR1
subunit in host murine neurons through a TNFa-dependent,
PKC/CaMKII-mediated pathway, which lowers the threshold
for induction of LTP in human glial chimeric mice.
Enhanced Learning in Humanized Chimeric Mice
Stable, long-lasting changes in synaptic function, such as those
revealed by our LTP studies, are thought to be involved in
learning andmemory (Lee and Silva, 2009). Since LTPwasmark-
edly enhanced in human glial chimeric mice, we next asked if
these mice also exhibited improved learning. We first assessed
whether auditory fear conditioning (AFC)—a task in which the
mice learn to fear an innocuous tone by pairing it with foot shock
(Zhou et al., 2009), and which does not require visual input
(rag2/ mice are blind)—was potentiated in the human glial
chimeras. To this end, we compared the rate of acquisition of
AFC in xenografted human glial chimeras to that of both allog-
rafted murine glial chimeras and unengrafted littermate controls
(Figure 6A). The allografted mice—which were also generated in
immunodeficient rag2 null hosts—received neonatal grafts of
A2B5+ cells isolated from transgenic mice with constitutive
EGFP expression, which allowed us to readily identify murine
donor cells. After just a single pairing of the tone with foot shock,
the human glial chimeric mice exhibited a significant enhance-
ment in learning of the tone foot shock association: they showed
greater fear to the tone asmeasured by scoring freezing behavior
(the cessation of all movement except for respiration) than did
either allografted chimeras or unengrafted controls (n = 5–20,
9.6 ± 1.0 months old, F = 18.9, two-way repeated-measures
ANOVA, p < 0.001). Moreover, after 3 continuous days of
training, humanized chimeric mice also showed enhanced AFC
during the 3 remaining days of testing, as manifested by their
higher levels of freezing in response to the conditioned tone
(p < 0.01, post hoc Bonferroni test). In contrast, neither murine
glial chimeric mice nor unengrafted controls manifested any
increase in freezing behavior during the same period, despite
having been subjected to an identical fear conditioning paradigm
(p > 0.05; Bonferroni test) (Figure 6A). Of note, no differences
were observed between the human glial chimeras and their
controls in the reaction to foot shock (n = 5, 9.6 ± 1.0 months
old, F = 0.08 by two-way ANOVA, p > 0.5) (Figure S5A), suggest-
ing that their respective nociceptive thresholds were analogous.
To specifically assess hippocampus-dependent learning, we
next prepared chimeric mice using rag1 immunodeficient mice
(maintained on a C57/Bl6 background), which differ from their
rag2 null counterparts (on a C3h background) by having normal
vision. We first compared the net engraftment of human GPCs,
as well as their relative differentiation into hNG2+ GPCs or
GFAP+ astroglia, in human glial chimeras established in rag1
null and rag2 null mice. We focused on hippocampal learning,
as this region was used for our analysis of LTP (Lee and Silva,ell Stem Cell 12, 342–353, March 7, 2013 ª2013 Elsevier Inc. 349
Figure 6. Humanized Chimeric Mice Learn
Faster than Controls
(A) Auditory fear conditioning assessed in a cohort
of human chimeric, mouse chimeric, and un-
engrafted control rag2 null mice. Chimeric mice
exhibit prolonged freezing behavior in test
chamber 2 during exposure to the tonal condi-
tioned stimulus when compared to unengrafted
mice and allografted mice (n = 5–20, *p < 0.05,
**p < 0.01, two-way repeated-measures ANOVA
with Bonferroni test, means ± SEM). This differ-
ence persisted throughout all 4 days.
(B) Contextual fear conditioning in human glial
chimeric mice and littermate control rag1 null
mice. Freezing behavior was quantified for
chimeric and unengrafted littermate controls
during the 2 min acclimatization period (n = 6, *p <
0.05, **p < 0.01, two-way repeated-measures
ANOVA with Bonferroni test). In addition the mean
discrimination ratio for each day was obtained
from freezing scores in the training chamber
and the alternative chamber (freezing in training
chamber/total freezing time). Chimeric mice
demonstrated significantly greater abilities to
discriminate the chambers (n = 8–13, *p < 0.05,
**p < 0.01, two-way repeated-measures ANOVA
with Bonferroni test).
(C) Barnes maze testing in chimeric and un-
engrafted rag1 null littermate controls. Chimeric
mice demonstrated a significant learning advan-
tage, as reflected in a shorter latency and fewer
errors in solving the maze (n = 6, *p < 0.05, **p <
0.01, two-way repeated-measures ANOVA with
Bonferroni test).
(D) Object-Location Memory Task (OLT) in
chimeric mice and their unengrafted rag1 null
littermate controls demonstrated a learning
advantage in chimeric mice via enhanced recog-
nition of the novel displaced object. Thalidomide eliminated the learning advantage of chimeric mice, suggesting that the learning enhancement was TNFa
mediated (n = 7, **p < 0.01, one-way ANOVA with Bonferroni test).
All data are plotted as means ± SEM. See also Figure S5.
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engraftment and differentiation of human GPCs in rag1 and
rag2 immunodeficient mice were indistinguishable from one
another (Figures S5B and S5C). On that basis, we next assessed
the effect of chimerization of rag1 null immunodeficient mice on
contextual fear conditioning (CFC), a hippocampal-dependent
task in which mice learn to fear a context in which they receive
a foot shock (Fanselow and Poulos, 2005). The human glial-
chimeric mice exhibited enhanced performance in CFC
throughout all 4 days of training (Figure 6B). By just the second
day, the human glial chimeric mice exhibited substantially
more rapid and robust CFC than their nonchimeric littermate
controls (n = 6, 6.9 ± 0.1 months of age, F = 14.8 by two-way
repeated-measures ANOVA, p = 0.003), and continued to
display enhanced CFC during the subsequent 2 days of CFC
training (Figure 6B). To exclude the possibility that a generalized
increase in freezing behavior could explain the observed differ-
ences, we also examined the context specificity of freezing
responses. In these experiments, the mice were placed in
a second chamber with a different floor and odor. Chimeric
mice exhibited superior discrimination between the two
contexts, suggesting stronger contextual learning, as opposed350 Cell Stem Cell 12, 342–353, March 7, 2013 ª2013 Elsevier Inc.to a nonspecific higher level of fear (n = 8–13, 7.6 ± 0.1 months,
p < 0.05, t test) (Figure 6B). No differences were observed in
the reaction times to foot shock between the human glial
chimeras and their rag1 null immunodeficient controls (n = 5,
9.6 ± 0.95 months, F = 0.08 by two-way ANOVA, p > 0.5)
(Figure S5A). Moreover, neither thermal nor mechanical sensi-
tivity were affected by chimerization of either rag1 or rag2 mice
(Figures S5D and S5E), suggesting that their respective nocicep-
tive thresholds were analogous.
To better assess the scope of performance enhancement in
the human glial chimeras, we next assessed their performance
in the Barnes maze, another hippocampal-dependent learning
task. In this spatial learning task mice learn the location of
a hole that leads to an escape/drop box. By just the second
day of serial daily testing, the human glial chimeras made
fewer errors and displayed a significantly shorter latency in
finding the drop box compared to their littermate controls
(n = 6, 7.4 ± 0.1months, F = 13.4 by two-way repeated-measures
ANOVA, p = 0.004) (Figure 6C). These differences persisted
throughout the four-trial testing period (n = 6, 7.4 ± 0.1 months,
F = 11.4, p = 0.007). With additional training, the unengrafted
control mice were capable of completing the task, indicating
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(Figure S5F).
Next, we tested the mice in the Object-Location Memory Task
(OLT), another hippocampal-dependent task (Manns and
Eichenbaum, 2009). OLT tests the ability of the animal to recog-
nize a familiar object in a novel location. Chimeric mice exhibited
a substantially greater preference for objects in novel locations
than their controls (58.6% ± 4.8% versus 41.8% ± 2.3%,
means ± SEM, n = 7, 7.2 ± 0.1 months, p = 0.008, t test)
(Figure 6D). Thalidomide treatment did not affect appreciably
the performance of the unengrafted littermate controls on
the OLT, but reduced the performance of the human glial
chimeric mice to the levels of controls (n = 7, 7.8 ± 0.1 months,
p = 0.82, t test) (Figure 6D). Thus, thalidomide selectively abro-
gated the chimerization-associated performance enhancement
of the human glial chimeras.
Together, these results indicate that relative to either unen-
grafted mice or mice allografted with A2B5+-sorted, EGFP+
murine GPCs, human glial chimeric mice exhibit enhanced
performance in four different learning tasks: AFC, CFC, Barnes
maze, and novel object location. Moreover, the analysis of AFC
indicates that alloengraftment by mouse GPCs did not affect
the learning of the recipient mice, supporting the notion that
the improved learning in the humanized chimeras resulted
from the presence of human glia, rather than from cell engraft-
ment per se. As an additional control, we also noted that social
interactions did not differ between human chimeras generated
by engraftment in rag1 mice and their littermate controls (n = 5,
6.9 ± 0.1 months, p > 0.05, t test) (Figures S5G and S5H), indi-
cating that chimerization did not seen to affect their interactions
with other mice.
DISCUSSION
Prior studies have documented that astrocytes regulate synaptic
transmission and actively participate in the synaptic efficiency of
neural circuits in the rodent CNS (Fields, 2004; Nedergaard and
Verkhratsky, 2012; Parpura and Verkhratsky, 2012; Rusakov
et al., 2011). A parallel, hitherto nonoverlapping line of work
has shown that human astrocytes are larger and far more struc-
turally complex than those of rodents (Colombo, 1996; Oberheim
et al., 2009); this has led to the hypothesis that astrocytic evolu-
tion has been critical to the increased scope and capacity of
central neural processing that have attended hominid evolution
(Colombo, 1996; Oberheim et al., 2006, 2012). In support of
this hypothesis, genomic studies have revealed that the greatest
differences in brain gene expression between humans and mice
are in glial transcripts (Miller et al., 2010).
In this study, we created human glial chimeric mice, in which
immunodeficient but otherwise normal mice were engrafted
neonatally with large numbers of human glial progenitors,
resulting in the widespread integration of human glia into the
mouse brain. By the time these mice reached adulthood, a large
proportion of their forebrain glia were replaced by human cells.
The chimerization was slowly progressive, so that extensive
infiltration of cortex and hippocampus by human cells was
evident by 4–12 months (Figure 1). The xenografted human
cells remained as NG2-defined glial progenitor cells or differen-
tiated as hGFAP+ astrocytes; remarkably, the latter maintainedCtheir characteristic, large, and complex hominid-selective
morphologies (Figure 2). In addition, some assumed the
characteristic long-distance fiber extensions of interlaminar
astrocytes, a domain-traversing astrocytic phenotype specific
to the hominid brain (Colombo, 2001; Colombo et al., 1995;
Oberheim et al., 2006). Electrophysiological analysis validated
that most EGFP+/hGFAP+/hNuclei+ human glia were proto-
plasmic astrocytes, based on their low input resistance, passive
membrane properties, extensive gap junction coupling, and
Ca2+ wave propagation (Figure 3).
The striking population of the recipient mouse brains by
human glia raised the possibility that the engrafted human cells
might significantly modulate information processing within the
hostmurine neural networks. Indeed, the basal level of excitatory
synaptic transmission was increased over a wide range of stim-
ulation intensities. The presence of human glia also enhanced
LTP in human glial chimeric hippocampal slices relative to
mice that had received conspecific murine glial progenitors or
vehicle injection (Figure 4). Our analysis showed that TNFa was
significantly elevated in the human glial chimeric brains, consis-
tent with the potentiation of AMPA-receptor-mediated currents
(Beattie et al., 2002; Stellwagen and Malenka, 2006). Additional
analysis suggested that TNFamay have directly facilitated inser-
tion of the GluR1 subunit into the plasma membrane (Hu et al.,
2007), perhaps via its increased phosphorylation at Ser831.
TNFa might also potentiate astrocytic glutamate release (Ni
and Parpura, 2009; Parpura and Zorec, 2010), which in turn
could increase GluR1 subunit phosphorylation by NMDA-
receptor-mediated activation of PKC (Figure 5) (Malinow and
Malenka, 2002). Both of these pathways might have contributed
to the enhancement of hippocampal LTP that we observed in the
human glial chimeras, although we found no evidence of
enhancement of NMDA receptor activation after engraftment
(Figure 4C). Importantly, we found that thalidomide, a BBB-
permeable inhibitor of TNFa, both diminished the enhancement
of postsynaptic AMPA receptor current and reduced LTP in
chimeric mice, yet had no such effects in unengrafted littermate
controls. Behavioral analyses then revealed that human glial
chimeric mice exhibited improved learning and memory in four
different tasks, including AFC, CFC, the Barnes Maze, and
OLT (Figure 6). As with the chimerization-associated enhance-
ment in LTP, the enhanced learning of chimericmice in the object
location recognition assay was eliminated by thalidomide treat-
ment (Figure 6D). Engraftment by neonatally delivered mouse
GPCs did not enhance LTP, AFC, or Barnes maze performance,
strongly suggesting that the potentiation of synaptic plasticity
and learning afforded by glial progenitor cell chimerization was
specific to human glia, and not a product of cell engraftment
per se (Figures 4B and 6A).
Together, these studies demonstrate that human astrocytes
generated within the mouse brain maintain their complex pheno-
type in a cell-autonomous fashion; they assume morphologies
and Ca2+ wave characteristics typical of the human brain, but,
to our knowledge, hitherto never observed in experimental
animals. These observations strongly support the notion that
the evolution of human neural processing, and hence the
species-specific aspects of human cognition, in part may reflect
the course of astrocytic evolution (Oberheim et al., 2006). As
such, these human glial chimeric mice may present a usefulell Stem Cell 12, 342–353, March 7, 2013 ª2013 Elsevier Inc. 351
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tive and pathological species-specific aspects of human glial
biology, may now be effectively studied in the live adult brain.
EXPERIMENTAL PROCEDURES
Isolation of Human and Murine Glial Progenitor Cells
Fetal glial cell progenitors were extracted from 17- to 22-week-old human
fetuses obtained at abortion. The forebrain ventricular and subventricular
zones were dissected free on ice and then were dissociated using papain/
DNAase as described (Windrem et al., 2004). All samples were obtained with
consent under approved protocols of the University of Rochester Research
Subjects Review Board. Human glial progenitor cells were isolated by
magnetic activated cell sorting, as described in the Supplemental Experi-
mental Procedures. In addition, murine A2B5+ cells were identically prepared
from newborn Tg(CAG-EGFP)B5Nagy/J pups (Jackson Laboratory).
Transfection and Differentiation
Human A2B5+/PSA-NCAM cells were transfected to express enhanced
EGFP, and were maintained as described in the Supplemental Experimental
Procedures.
Transplantation
Human glial chimeras were prepared as described, using either rag1/ or
rag2/ immunodeficient mice (as described in Windrem et al., 2008, though
using mice wild-type for myelin); see Supplemental Experimental Procedures
for additional detail. All experiments were approved by the University of
Rochester’s Research Animal Care and Use Committee.
Quantitative Immunohistochemistry
Chimeric mice and littermate controls (ranging from 2weeks to 20months, de-
pending upon experimental endpoint) were perfusion-fixed, processed histo-
logically, and analyzed as described in the Supplemental Experimental
Procedures.
Electrophysiological Characterization of Human Glia in Chimeric
Mice
Patch-clamp assessment of engrafted human glia was performed in slice
preparations under two-photon microscopy, as detailed in the Supplemental
Experimental Procedures.
LTP
Slice preparations of both chimeric mice and their littermate controls (with an
age range of 7–20 months) were used for recordings of fEPSPs and analysis of
activity-dependent changes in hippocampal synaptic strength, as outlined in
the Supplemental Experimental Procedures.
Ca2+ Imaging and Photolysis of Caged Ca2+
Chimeric mice (with an age range of 4–10 months) were used for imaging intra-
cellular Ca2+ in xenografted human glia. In addition, as positive controls,
surgical resections of human cortex (n = 3 patients, 30.6 ± 8.8 years old)
were obtained with patient consent and the approval of the University of
Rochester Research Subjects Review Board; all samples were prepared for
physiological assessment and analyzed as described in the Supplemental
Experimental Procedures.
Detection of Human TNFa in Human Glial Chimeras
RNA isolation, PCR primer design, reverse transcription, and PCR reaction
conditions and analysis were all as described in the Supplemental Experi-
mental Procedures.
Learning Tasks and Behavioral Assessment
AFC, CFC, Barnes maze navigation, object location memory, Crawley’s social
interaction tasks, and both thermal andmechanical sensitivity thresholds were
assessed in human glial chimeric and control mice; the latter included allog-
rafted and/or unengrafted negative controls. All tests and analyses were per-
formed as outlined in the Supplemental Experimental Procedures.352 Cell Stem Cell 12, 342–353, March 7, 2013 ª2013 Elsevier Inc.Statistics
All data are presented and graphed as means ± SEM. The Steel-Dwass test
was used to assess the relative diameters of cells, input resistances, and
Ca2+ velocities, all variables for which normality of the data could not be
assumed. For other electrophysiological data, either Student’s t test for two
groups or two-way ANOVA with Bonferroni post hoc t tests were used. For
behavioral data, Student’s t test or two-way repeated-measures ANOVA
with Bonferroni post hoc test were used. Normality of the data was assessed
by the Shapiro-Wilk test. p < 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes five figures and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2012.12.015.
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